MPP

DEVICE2 trials

Sponsors

Abbott Medical Devices

Conditions

Heart Failure

Unknown Phase

MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing

TerminatedNCT02006069

Abbott Medical DevicesHeart Failure

Start: 2013-12-31End: 2021-05-30Updated: 2023-05-17

MultiPoint Pacing™ Post Market Study

CompletedNCT02832622

Abbott Medical DevicesHeart Failure

Start: 2016-07-31End: 2019-07-15Updated: 2021-02-17

Related Papers

Rationale and design of a randomized clinical trial to assess the safety and efficacy of multipoint pacing therapy: MOre REsponse on Cardiac Resynchronization Therapy with MultiPoint Pacing (MORE-CRT MPP-PHASE II).

2018-12-0815 citations

Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP)

EP Europace2016-05-1783 citations